CANF

Can-Fite BioPharma Ltd.

3.400

-0.040-1.16%

Pre Market: 3.400 0.000 0.00%08:38 08/17 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE3.550/3.450

TODAY RANGE3.400-3.550

VOL17.33K

MARKET CAP7.46M

52 WEEK RANGE2.560-13.60

AVG VOL (3M)1.41M

% TURNOVER0.81%

TURNOVER--

P/E (TTM)-0.0019

% RANGE2.73%

EPS(TTM)-1,791.0231

P/E(FORWARD)-5.1176

P/B0.0054

BVPS640.69

DIVIDEND--

P/S0.0750

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP7.46M

SHARES OUTSTANDING2.14M

NEXT EARNINGS--

FREE FLOAT2.14M

LOT SIZE1

EX-DATE01/05/2026

News

Press Releases

Financial Reports

Profile

NASDAQ·2d ago
Can-Fite Releases Positive Data For Namodenoson In Treating Pancreatic Cancer
TipRanks·2d ago
Can-Fite Reports New Data Supporting Namodenoson Combo Strategy in Pancreatic Cancer
TipRanks·08/12 11:28
Can-Fite BioPharma Advances Phase III Drug Candidates With Strengthened FDA and EMA Pathways
TipRanks·08/03 11:55
Can-Fite submits Piclidenoson clinical study protocol to Bambino Gesu
TipRanks·08/03 11:27
Can-Fite BioPharma Starts First Piclidenoson Trial in Rare Lowe Syndrome
TipRanks·07/20 11:27
Can-Fite’s Namodenoson Pancreatic Cancer Data Accepted for ESMO 2026 Presentation
TipRanks·07/14 20:33
Can-Fite BioPharma Wins Australian Patent Backing Namodenoson in Liver and Pancreatic Cancer
TipRanks·07/14 11:15
Can-Fite BioPharma secures Australian Patent Office allowance for namodenoson
TipRanks·07/06 11:27
Can-Fite Completes Key Phase 3 Psoriasis Enrolment Milestone for Piclidenoson
TipRanks·07/06 11:15
Can-Fite BioPharma enrolls 247 patients in Piclidenoson trial
Dow Jones·07/02 11:09
Can-Fite Biopharma Price Target Raised to $8.00/Share From $5.00 by HC Wainwright & Co.
TipRanks·07/02 10:00
Can-Fite BioPharma price target raised to $8 from $5 at H.C. Wainwright
Seeking Alpha·07/02 09:14
Biggest stock movers Thursday: FIZZ, CANF, and more
NASDAQ·07/02 03:16
Top Biotech Gainers: CANF Climbs, RGNT Gears Up For Europe Launch, RNAZ, ELTX On Watch
NASDAQ·07/01 11:57
Can-Fite's Namodenoson Shows Survival Benefits In Pancreatic Cancer; Stock Jumps Pre-Market

Same Industry

Name/Symbol

Change%

Price

Can-Fite BioPharma Ltd.

CANF

-1.16%

3.400

McKesson

MCK

-0.24%

866.93

Biogen Inc

BIIB

+1.63%

212.55

Amgen Inc

AMGN

-0.63%

415.21

SHPG

CELG-RT

Lilly Eli & Co

LLY

+0.25%

CELG

Therapeuticsmd Inc

TXMD

-0.48%

2.070

Johnson & Johnson

JNJ

+0.78%

262.37

ABBV

Zoetis Inc

ZTS

-2.70%

73.79

Gilead Sciences Inc

GILD

+0.16%

138.36

Novo-Nordisk A/S

NVO

-1.78%

45.89

Bristol-Myers Squibb Co

BMY

-1.27%

63.83

Alexion Pharms

ALXN

+1.70%

182.50

Pfizer

PFE

+0.30%

26.87

Sanofi FR

SNY

-0.14%

43.72

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

-0.55%

150.88

Dr Reddys Labs

RDY

-1.18%

12.13

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.